FDA
-
-
-
-
-
-
-
Medtronic reports fourth quarter and full year fiscal 2026 results; delivers highest annual revenue growth in 10 years
-
-
-
-
-
-
-
Orchestra BioMed receives $15 million from Ligand under financing agreement
-
-
-
-
-
-
-
Orchestra BioMed to Present AVIM Therapy Clinical and Mechanistic Data at HRS 2026
-
-
-
-
-
-
-
Orchestra BioMed Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update
-
-
-
-
-
-
-
Medtronic Diabetes expands access to full-stack insulin delivery solutions with Medicare access and new FDA clearances
-
-
-
-
-
-
-
Medtronic receives FDA clearance for Hugo robotic surgery system
-
-
-
-
-
-
-
Medtronic reports strong second quarter fiscal 2026 financial results, enterprise growth drivers accelerate momentum
-
326,130 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

